RCM
PHAS
RA Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,850,000
| Closed | -$3.76M | – | 109 |
|
|
2022
Q1 | $3.76M | Hold |
2,850,000
| – | – | 0.08% | 90 |
|
|
2021
Q4 | $7.44M | Hold |
2,850,000
| – | – | 0.13% | 87 |
|
|
2021
Q3 | $8.86M | Hold |
2,850,000
| – | – | 0.12% | 81 |
|
|
2021
Q2 | $10.6M | Hold |
2,850,000
| – | – | 0.17% | 72 |
|
|
2021
Q1 | $9.86M | Buy |
+2,850,000
| New | +$9.86M | 0.15% | 72 |
|